TrialClinical cancer research : an official journal of the American Association for Cancer Research2019

A Phase I/II Trial of Carfilzomib, Pegylated Liposomal Doxorubicin, and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma.

Mark A Schroeder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.